期刊文献+

产气荚膜梭菌ε毒素重组突变体大肠杆菌表达条件的优化 被引量:1

Optimization of Expression Conditions for Recombinant Mutants of Clostridium perfringens ε-toxin in E.coli
下载PDF
导出
摘要 为优化产气荚膜梭菌ε毒素重组蛋白的表达条件,以前期构建的产气荚膜梭菌ε毒素重组突变体为基础,通过控制变量法确定诱导温度、诱导时间、IPTG诱导浓度以及诱导时菌液浓度等原核蛋白表达条件。结果表明,ε毒素的重组突变体在37℃、菌液OD_(600)值为0.895~1.295,1.6 mM IPTG诱导6 h条件下可溶性表达量最高。这为下一步大规模生产ε毒素基因工程亚单位疫苗奠定基础。 To optimize the expression conditions of the ε-toxin recombinant protein of Clostridium perfringens and lay the foundation for the next large-scale production ofε-toxin genetic engineering subunit vaccines.Based on the recombinant mutant of Clostridium perfringens epsilon toxin constructed in the previous stage,the prokaryotic protein expression conditions such as induction temperature,induction time,IPTG induction concentration and bacterial solution concentration during induction were determined by the control variable method.The results showed that the recombinant mutant of epsilon toxin had the highest soluble expression under the condition of 6 h induced by 1.6 mM IPTG at 37℃and the OD_(600) value of the bacterial solution was 0.895~1.295.
作者 朱真 杜吉革 薛麒 李启红 印春生 张莹辉 李倩琳 姚文生 陈小云 ZHU Zhen;DU Ji-ge;XUE Qi;LI Qi-hong;YIN Chun-Sheng;ZHANG Ying-hui;LI Qian-lin;YAO Wen-sheng;CHEN Xiao-yun(China Institute of Veterinary Drug Control ,Beijing 100081,China)
出处 《中国兽药杂志》 2021年第6期8-14,共7页 Chinese Journal of Veterinary Drug
关键词 产气荚膜梭菌 ε毒素 基因工程亚单位疫苗 蛋白表达 Clostridium perfringens εtoxin genetic engineering subunit vaccine protein expression
  • 相关文献

参考文献6

二级参考文献58

  • 1LIUNa LUMin.The signal transduction pathways and molecules for ES cells self-renewal[J].Chinese Science Bulletin,2005,50(8):721-726. 被引量:7
  • 2李军,吕长荣,窦琳,窦忠英.小鼠Nanog基因原核表达载体的构建及表达[J].中国农业科学,2007,40(2):373-378. 被引量:11
  • 3高见,赵莉,任皎,张卉,阮力,田厚文.密码子优化的HPV16 L2E7基因在大肠杆菌中高效表达[J].中国医学科学院学报,2007,29(5):579-583. 被引量:4
  • 4HASSAN K A, ELBOURNE L D,TETU S G,et al. Genomic analyses of Clostridium perfringens isolates from five toxino- types[J]. Research in Microbiology, 2015, 166(4):255-263.
  • 5RUMAH K R,LINDEN J,FISCHETI'I V A,et al. Isolation of Clostridiztm perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmen- tal triggers of the disease[J].PLoS One,2013,8(10):271-272.
  • 6DANIL K,ST LEGER J A,DENNISON S,et at. Clostridium perfringens septicemia in a long-beaked common dolphin Del- phinus capensis:An etiology of gas bubble accumulation in cetaceans[J].Dis Aquat Organ,2014,111 (3) : 183-190.
  • 7LEE H L, CHO S Y, LEE D G, et al. A fatal spontaneous gas gangrene due to clostridium perfringens during neutropenia of allogeneic stem cell transplantation: Case report and litera- ture review[J]. Infect Chemother,2014,46(3):199-203.
  • 8BOKORI-BROWN M,HALL C A,VANCE C,et al. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombi- nant vaccine candidate against enterotoxemia[J]. Vaccine, 2014,32(23 ) : 2682-2687.
  • 9YONOGI S,MATSUDA S,KAWAI T,et al. BEC,a novel en- terotoxin of Clostridium perfringens found in human clinical isolates from acute gastroenteritis outbreaks [J]. Infect Im- mun, 2014,82(6):2390-2399.
  • 10TOBIN C A, SANGER J R. Clostridium perfringens infection following carpal tunnel release [ J ]. Hand (N Y), 2013,8 ( 1 ) :64-66.

共引文献21

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部